Search

Displaying 1 - 25 of 207 items.

Pages

Post-Coital Oral Emergency Contraception

Post-coital oral emergency contraception is used for the prevention of pregnancy after intercourse. The contraception comes in the form of pills, often collectively referred to as morning-after pills. Post-coital use of morning-after pills separates them from traditional contraception which is either a continual preventative process, such as the birth control pill, or used during intercourse, such as condoms.

Format: Articles

Subject: Processes, Reproduction

The Birth Control Pill

The birth control pill, more commonly known as "the pill" is a form of contraception taken daily in pill form and consisting of synthetic hormones formulated to prevent ovulation, fertilization, and implantation of a fertilized egg. The US Food and Drug Administration (FDA) approved the first birth control pill, Enovid, in June 1960. It was the first contraceptive pill marketed worldwide. Since then a number of different pills have been developed, which differ in hormone type and dosage, and whether they contain one hormone (the minipill) or two (the combination pill).

Format: Articles

Subject: Technologies, Reproduction

Plan B: Emergency Contraceptive Pill

Plan B is a progestin-only emergency contraceptive pill (ECP) that can be taken within seventy-two hours of unprotected sex in order to prevent an unwanted pregnancy. Plan B was created in response to the United States Food and Drug Administration's (US FDA) 1997 request for new drug applications (NDAs) for a dedicated ECP product, and was approved for sales in the US in 1999. Duramed, a subsidiary of Barr Pharmaceuticals, manufactures Plan B for The Women's Capital Corporation (WCC), which owns the patent for Plan B.

Format: Articles

Subject: Technologies, Reproduction

“Explaining Recent Declines in Adolescent Pregnancy in the United States: The Contribution of Abstinence and Improved Contraceptive Use” (2007), by John S. Santelli, Laura Duberstein Lindberg, Lawrence B. Finer, and Susheela Singh

In “Explaining Recent Declines in Adolescent Pregnancy in the United States: The Contribution of Abstinence and Improved Contraceptive Use,” hereafter “Explaining Recent Declines,” researchers John S. Santelli, Laura Duberstein Lindberg, Lawrence B. Finer, and Susheela Singh discuss what led to the major decline in US adolescent pregnancy rates from 1995 to 2002. Working with the Guttmacher Institute, a reproductive health research organization, they found that the decline in US adolescent pregnancy rates between 1995 and 2002 was primarily due to improved contraceptive use.

Format: Articles

Subject: Publications, Reproduction

Enovid: The First Hormonal Birth Control Pill

Enovid was the first hormonal birth control pill. G. D. Searle and Company began marketing Enovid as a contraceptive in 1960. The technology was created by the joint efforts of many individuals and organizations, including Margaret Sanger, Katharine McCormick, Gregory Pincus, John Rock, Syntex, S.A. Laboratories, and G.D. Searle and Company Laboratories.

Format: Articles

Subject: Technologies, Reproduction

Min Chueh Chang (1908-1991)

As one of the researchers involved in the development of the oral contraceptive pill, Min Chueh Chang helped to revolutionize the birth control movement. Although best known for his involvement with "the pill," Chang also made a number of discoveries throughout his scientific career involving a range of topics within the field of reproductive biology. He published nearly 350 articles in scientific journals.

Format: Articles

Subject: People, Reproduction

John Charles Rock (1890-1984)

Born on 24 March 1890 in Marlborough, Massachusetts, to Ann and Frank Rock, John Charles Rock was both a devout Catholic and one of the leading investigators involved in the development of the first oral contraceptive pill. In 1925 he married Anna Thorndike, with whom he later had five children. He spent over thirty years of his career as a clinical professor of obstetrics at Harvard Medical School, and in 1964 the Center for Population Studies of the Harvard School of Public Health established the John Rock Professorship.

Format: Articles

Subject: People, Reproduction

Katharine McCormick (1876-1967)

Katharine Dexter McCormick, who contributed the majority of funding for the development of the oral contraceptive pill, was born to Josephine and Wirt Dexter on 27 August 1875 in Dexter, Michigan. After growing up in Chicago, Illinois, she attended the Massachusetts Institute of Technology (MIT), where she graduated in 1904 with a BS in biology. That same year, she married Stanley McCormick, the son of Cyrus McCormick, inventor and manufacturer of the mechanized reaper.

Format: Articles

Subject: People, Ethics, Reproduction

Thesis: Dismantling Legal Constraints to Contraception in the 1900s

In the late nineteenth century, the Comstock Act of 1873 made the distribution of contraception illegal and classified contraception as an obscenity. Reflecting the predominant attitude towards contraception at the time, the Comstock Act was the first federal anti-obscenity law that targeted contraception. However, social acceptance of birth control changed at the turn of the twentieth century. In this thesis, I analyzed legislation, advocates, and literature pertinent to that social change to report on the events leading up to the decriminalization of contraception.

Format: Essays and Theses

Subject: People, Legal, Reproduction

Oral Glucose Tolerance Test for Gestational Diabetes

In the twentieth century, researchers developed the oral glucose tolerance test, or OGTT, as a method to diagnose different types of diabetes, a medical condition that causes blood sugar levels to become abnormally high. During the test, a healthcare provider measures a person’s blood sugar levels before and after the person consumes a predetermined amount of glucose solution. While not exclusively used for pregnant women, an OGTT may test for gestational diabetes which, according to the International Diabetes Federation, affected one in six pregnancies worldwide in 2019.

Format: Articles

Subject: Technologies, Reproduction, Experiments

Gregory Goodwin Pincus (1903-1967)

Gregory Goodwin Pincus, one of the original researchers responsible for the development of the first oral contraceptive pill, was born in Woodbine, New Jersey, on 19 April 1903 to Russian Jewish parents. In 1924 Pincus received his BS degree from Cornell University, and in 1927 he received his MS and PhD from Harvard University, having studied under William Ernest Castle and William John Crozier.

Format: Articles

Subject: People, Reproduction

Copper Intrauterine Device (IUD)

The copper intrauterine device, or IUD, is a long-term, reversible contraceptive first introduced by Howard Tatum and Jamie Zipper in 1967. Health care providers place an IUD inside a woman’s uterus to prevent pregnancy. Copper IUDs are typically made of T-shaped plastic with some portion covered with exposed copper. Prior to the invention of the first IUDs, women had few long-term options for safe and reliable birth control. Those options mostly consisted of barrier methods and the oral birth control pill, which were only effective if used correctly and consistently.

Format: Articles

Subject: Technologies

Progestin: Synthetic Progesterone

Progestin is a synthetic form of progesterone, a naturally occurring hormone, which plays an important role in the female reproductive cycle. During the 1950s two types of progestin that were later used in birth control pills were created, norethindrone and norethynodrel. In 1951 Carl Djerassi developed norethindrone at Syntex, S.A. laboratories located in Mexico City, receiving a patent on 1 May 1956. In 1953 Frank Colton developed norethynodrel at G.D. Searle and Company laboratories located in Chicago, receiving a patent on 29 November 1955.

Format: Articles

Subject: Technologies, Reproduction

The Time Has Come: A Catholic Doctor's Proposals to End the Battle over Birth Control (1963), by John Rock

In 1963, Roman Catholic fertility doctor John Rock published The Time Has Come: A Catholic Doctor's Proposals to End the Battle over Birth Control, a first-person treatise on the use of scientifically approved forms of birth control for Catholic couples. The first contraceptive pill, called Enovid, had been on the market since June 1960, and Rock was one of the leading researchers in its development. In The Time Has Come, Rock explicitly describes the arguments for and against the use of birth control from both a religious and a scientific perspective.

Format: Articles

Subject: Publications, Religion, Reproduction

Barbara Seaman (1935–2008)

Barbara Seaman was a writer, investigator, and advocate for female healthcare rights during the twentieth century in the United States. Seaman’s work addressed the gendered prejudice she observed in the US healthcare system and argued that women of the 1960s lacked the proper tools to make informed decisions about pregnancy care, breastfeeding, childbirth, and contraception. Seaman wrote the book The Doctor’s Case Against the Pill in 1969 to expose the dangers in prescribing and consuming high doses of estrogen in the form of birth control.

Format: Articles

Subject: People

The Dalkon Shield

The Dalkon Shield was an intrauterine contraceptive device (IUD) that women used in the early 1970s and 1980s. Produced by the A.H. Robins Company in the US, the Dalkon Shield was a contraceptive device placed directly into a woman’s uterus that was supposed to prevent the development of a fetus in the uterus. In the 1980s, researchers uncovered an array of severe birth defects and injuries caused by the Dalkon shield, including pelvic infection, infertility, and death of the user. Eventually the A.H.

Format: Articles

Subject: Technologies

"The Inductive Capacity of Oral Mesenchyme and Its Role in Tooth Development" (1969-1970), by Edward J. Kollar and Grace R. Baird

Between February 1969 and August 1970 Edward Kollar and Grace Baird, from the University of Chicago in Chicago, Illinois, published three papers that established the role of the mesenchyme in tooth induction. Drawing upon a history of using tissue interactions to understand differentiation, Kollar and Baird designed their experiments to understand how differentiated structures become specified. Their work overturned a widely accepted model that epithelium controls the identity of the structure, a phenomenon called structural specificity.

Format: Articles

Subject: Experiments

First American Birth Control Clinic (The Brownsville Clinic), 1916

On 16 October 1916, Margaret Sanger opened one of the first birth control clinics in the United States in Brooklyn, New York, which some have called the Brownsville Clinic. Located at 46 Amboy Street, the clinic was a place where Sanger and her staff verbally communicated with women seeking information about birth control. During the early 1900s, both birth control and abortion were illegal in the US, and publication or circulation of information on both topics was deemed obscene and illegal by the federal Comstock Act.

Format: Articles

Subject: Organizations

Estrogen and the Menstrual Cycle in Humans

Estrogen is the primary sex hormone in women and it functions during the reproductive menstrual cycle. Women have three major types of estrogen: estrone, estradiol, and estriol, which bind to and activate receptors within the body. Researchers discovered the three types of estrogen over a period of seven years, contributing to more detailed descriptions of the menstrual cycle. Each type of estrogen molecule contains a slightly different arrangement or number of atoms that in turn causes some of the estrogens to be more active than others.

Format: Articles

Subject: Theories, Reproduction

Hormone Releasing Intrauterine Devices

Hormone releasing intrauterine devices or hormonal IUDs are contraceptive devices placed in a woman’s uterus to prevent pregnancy by continuously releasing a low dose of certain hormones. Jouri Valter Tapani Luukkainen, a medical researcher at the University of Helsinki, introduced the first hormonal IUD in 1976. Luukkainen’s IUD was a plastic device shaped like a capital T.

Format: Articles

Subject: Technologies

The Development of Mifepristone for Use in Medication Abortions

In the 1980s, researchers at the pharmaceutical company Roussel-Uclaf in Paris, France, helped develop a biological compound called mifepristone. When a woman takes it, mifepristone interferes with the function of hormones involved in pregnancy and it can therefore be used to terminate pregnancies. In 2000, the US Food and Drug Administration approved mifepristone, also called RU 486, as part of a treatment to induce abortions using drugs instead of surgery, a method called medication abortion.

Format: Articles

Subject: Reproduction

Margaret Higgins Sanger (1879-1966)

Margaret Higgins Sanger advocated for birth control in the United States and Europe during the late nineteenth and early twentieth centuries. Although people used contraceptives prior to the twentieth century, in the US the 1873 Comstock Act made the distribution of information relating to the use of contraceptives illegal, and similar state-level Comstock laws also classified discussion and dissemination of contraceptives as illegal.

Format: Articles

Subject: People, Reproductive Health Arizona, Reproduction, Outreach

Evangelium Vitae (1995), by Pope John Paul II

The encyclical entitled "Evangelium Vitae," meaning "The Gospel of Life," was promulgated on 25 March 1995 by Pope John Paul II in Rome, Italy. The document was written to reiterate the view of the Roman Catholic Church on the value of life and to warn against violating the sanctity of life. The document focuses on right to life issues including abortion, birth control, and euthanasia, but also touches on other concepts relevant to embryology, such as contraception, in vitro fertilization, sterilization, embryonic stem cell research, and fetal experimentation.

Format: Articles

Subject: Religion, Reproduction

Diethylstilbestrol (DES) in the US

Diethylstilbestrol (DES) is an artificially created hormone first synthesized in the late 1930s. Doctors widely prescribed DES first to pregnant women to prevent miscarriages, and later as an emergency contraceptive pill and to treat breast cancer. However, in 1971, physicians showed a link between DES and vaginal cancer during puberty in the children of women who had taken DES while pregnant. Consequently, the US Food and Drug Administration (FDA) banned its use during pregnancy.

Format: Articles

Subject: Reproduction, Technologies

Pope Paul VI (1897-1978)

Pope Paul VI, born Giovanni Battista Enrico Antonio Maria Montini, has been crucial to the clarification of Roman Catholic views on embryos and abortion in recent history. His 1968 encyclical "Humanae Vitae" spoke to the regulation of birth through various methods of contraception and sterilization. This encyclical, a result of Church hesitancy to initiate widespread discussion of the issue in a council of the Synod of Bishops, led to much controversy in the Church but established a firm Catholic position on the issues of birth control and family planning.

Format: Articles

Subject: People, Religion, Reproduction

Pages